Cargando…

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer

BACKGROUND: Resistance to antiestrogen therapy is a major clinical challenge in the treatment of estrogen receptor α (ER)-positive breast cancer. The aim of the study was to explore the growth promoting pathways of antiestrogen resistant breast cancer cells to identify biomarkers and novel treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsen, Sarah L, Yde, Christina W, Laenkholm, Anne-Vibeke, Rasmussen, Birgitte B, Duun-Henriksen, Anne Katrine, Bak, Martin, Lykkesfeldt, Anne E, Kirkegaard, Tove
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392616/ https://www.ncbi.nlm.nih.gov/pubmed/25885472 http://dx.doi.org/10.1186/s12885-015-1210-4

Ejemplares similares

Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment
por: Larsen, Sarah L., et al.
Publicado: (2015)

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
por: Løkkegaard, Sanne, et al.
Publicado: (2021)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
por: Elias, D., et al.
Publicado: (2019)

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
por: Frogne, Thomas, et al.
Publicado: (2009)

Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation
por: Larsen, SS, et al.
Publicado: (2000)

Resveratrol Sensitizes Tamoxifen in Antiestrogen-Resistant Breast Cancer Cells with Epithelial-Mesenchymal Transition Features
por: Shi, Xiao-Peng, et al.
Publicado: (2013)

The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
por: Suba, Zsuzsanna
Publicado: (2015)

HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2016)

Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor
por: Li, Ye, et al.
Publicado: (2021)

FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties
por: Díaz, Mario, et al.
Publicado: (2021)

Protein Aggregation Patterns Inform about Breast Cancer Response to Antiestrogens and Reveal the RNA Ligase RTCB as Mediator of Acquired Tamoxifen Resistance
por: Direito, Inês, et al.
Publicado: (2021)

Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
por: Larsen, Martin J., et al.
Publicado: (2013)

Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs
por: Semina, Svetlana E., et al.
Publicado: (2018)

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer
por: Lykkesfeldt, Anne E, et al.
Publicado: (2009)

Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
por: Woo, Yu Mi, et al.
Publicado: (2015)

Development and characterization of a tamoxifen-resistant breast carcinoma xenograft
por: Naundorf, H, et al.
Publicado: (2000)

Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery
por: Stovgaard, Elisabeth Specht, et al.
Publicado: (2012)

Differential Response to α-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells
por: Nass, Norbert, et al.
Publicado: (2014)

Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2012)

The Antiestrogens Tamoxifen and Fulvestrant Abolish Estrogenic Impacts of 17α-ethinylestradiol on Male Calling Behavior of Xenopus laevis
por: Hoffmann, Frauke, et al.
Publicado: (2012)

New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane
por: HOLE, STINE, et al.
Publicado: (2015)

Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
por: Jiang, Min, et al.
Publicado: (2013)

Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2013)

Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers
por: Linares, Aurélien, et al.
Publicado: (2019)

The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update
por: Huang, Lan, et al.
Publicado: (2020)

Ninth grade school performance in Danish childhood cancer survivors
por: Andersen, Klaus Kaae, et al.
Publicado: (2017)

Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer
por: Joshi, Tejal, et al.
Publicado: (2016)

Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men
por: Moustsen, Ida Rask, et al.
Publicado: (2019)

OR11-02 Structural Determinants of Pure Antiestrogenic Activity
por: Vallet, Amandine, et al.
Publicado: (2023)

Antiestrogen- and tamoxifen-induced effects on calcium-activated chloride currents in epithelial cells carrying the ∆F508-CFTR point mutation
por: Imberti, Roberto, et al.
Publicado: (2018)

An empirical Bayes model for gene expression and methylation profiles in antiestrogen resistant breast cancer
por: Jeong, Jaesik, et al.
Publicado: (2010)

Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data
por: Krøigård, Anne Bruun, et al.
Publicado: (2016)

Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis
por: Krøigård, Anne Bruun, et al.
Publicado: (2015)

Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression
por: Krøigård, Anne Bruun, et al.
Publicado: (2018)

Estrogenic or antiestrogenic therapies for multiple myeloma?
por: Sola, Brigitte, et al.
Publicado: (2007)

ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
por: Kalyuga, Maria, et al.
Publicado: (2012)

Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells
por: Walter, William, et al.
Publicado: (2015)

ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
por: Zhang, Jianbo, et al.
Publicado: (2017)

Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER(+) Breast Cancer
por: Servetto, Alberto, et al.
Publicado: (2021)

RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families
por: Larsen, Martin J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_knq2mdqg6lur9o4g254bohbmbu